Breast PET to reduce unnecessary biopsies
Department of Radiology
Many professionals involved in the detection and treatment of breast cancer are recognizing the value of the Solo II Breast PET and CMR Naviscan’s suite of breast cancer detection tools. With greater sensitivity and specificity, identifying tumors as small as 1.7mm, the Breast PET results in earlier detection and a greater probability that treatment regimens will be successful. Coupled with being able to accommodate a larger population of diagnosed patients, the CMR Naviscan suite of products are convincing more and more breast surgeons, radiologists and oncologists of their value in the fight against breast cancer. In addition, there are substantial economic benefits that result in greater savings for the healthcare industry.
Have a question or need more information? Have a CMR Naviscan representative contact you.